T1	Pharmacological_substance 27 41	5-fluorouracil
N1000 	Reference T1 MeSH:D005472	5-fluorouracil
T2	Disorder 53 66	neurotoxicity
N1 	Reference T2 UMLS:C0235032	neurotoxicity
T3	Disorder 85 127	dihydropyrimidine dehydrogenase deficiency
N2 	Reference T3 UMLS:C1959620	dihydropyrimidine dehydrogenase deficiency
T5	Pharmacological_substance 130 144	5-Fluorouracil
N1001 	Reference T5 MeSH:D005472	5-Fluorouracil
T6	Disorder 269 281	colon cancer
N3 	Reference T6 UMLS:C0007102	colon cancer
T7	Disorder 283 293	Stomatitis
N4 	Reference T7 UMLS:C0038362	Stomatitis
T8	Disorder 295 303	diarrhea
N5 	Reference T8 UMLS:C0011991	diarrhea
T9	Disorder 305 315	dermatitis
N6 	Reference T9 UMLS:C0011603	dermatitis
T10	Disorder 321 337	myelosuppression
N7 	Reference T10 UMLS:C0854467	myelosuppression
T11	Disorder 351 361	toxicities
N8 	Reference T11 UMLS:C0600688	toxicities
T12	Pharmacological_substance 365 369	5-FU
N1002 	Reference T12 MeSH:D005472	5-FU
N1003 	Reference T12 MeSH:D005472	5-FU
T13	Disorder 435 454	neurologic toxicity
N9 	Reference T13 UMLS:C0600688	neurologic toxicity
T16	Pharmacological_substance 543 547	5-FU
N1004 	Reference T16 MeSH:D005472	5-FU
N1005 	Reference T16 MeSH:D005472	5-FU
T17	Disorder 549 563	DPD deficiency
N10 	Reference T17 UMLS:C1959620	DPD deficiency
N11 	Reference T17 UMLS:C1959620	DPD deficiency
T19	Disorder 661 667	Cancer
N12 	Reference T19 UMLS:C0006826	Cancer
N13 	Reference T19 UMLS:C1306459	Cancer
T20	Disorder 769 788	neurologic toxicity
N14 	Reference T20 UMLS:C0600688	neurologic toxicity
T21	Pharmacological_substance 871 875	5-FU
N1006 	Reference T21 MeSH:D005472	5-FU
N1007 	Reference T21 MeSH:D005472	5-FU
T22	Disorder 881 893	colon cancer
N15 	Reference T22 UMLS:C0007102	colon cancer
T23	Disorder 922 931	mucositis
N16 	Reference T23 UMLS:C0333355	mucositis
T24	Disorder 933 956	desquamating dermatitis
T25	Disorder 968 984	myelosuppression
N17 	Reference T25 UMLS:C0854467	myelosuppression
T26	Disorder 990 1009	neurologic toxicity
N18 	Reference T26 UMLS:C0600688	neurologic toxicity
T30	Disorder 1353 1372	neurologic toxicity
N19 	Reference T30 UMLS:C0600688	neurologic toxicity
T31	Disorder 1543 1557	DPD deficiency
N20 	Reference T31 UMLS:C1959620	DPD deficiency
N21 	Reference T31 UMLS:C1959620	DPD deficiency
T32	Disorder 1611 1621	toxicities
N22 	Reference T32 UMLS:C0600688	toxicities
T33	Pharmacological_substance 146 150	5-FU
N1008 	Reference T33 MeSH:D005472	5-FU
N1009 	Reference T33 MeSH:D005472	5-FU
T36	Subject 72 79	patient
T37	Pharmacological_substance 158 192	analogue of pyrimidine nucleosides
T38	Disorder 233 237;275 281	head cancer
N23 	Reference T38 UMLS:C0751177	head cancer
T39	Disorder 242 246;275 281	neck cancer
N24 	Reference T39 UMLS:C0746787	neck cancer
T40	Disorder 248 254;275 281	breast cancer
N25 	Reference T40 UMLS:C0006142	breast cancer
T41	Disorder 256 263;275 281	ovarian cancer
N26 	Reference T41 UMLS:C1140680	ovarian cancer
T15	Subject 668 676	patients
T45	Pharmacological_substance 695 699	5-FU
N1010 	Reference T45 MeSH:D005472	5-FU
N1011 	Reference T45 MeSH:D005472	5-FU
T47	Subject 894 901	patient
T49	Pharmacological_substance 1178 1182	5-FU
N1012 	Reference T49 MeSH:D005472	5-FU
N1013 	Reference T49 MeSH:D005472	5-FU
T50	Pharmacological_substance 1435 1439	5-FU
N1014 	Reference T50 MeSH:D005472	5-FU
N1015 	Reference T50 MeSH:D005472	5-FU
T51	Pharmacological_substance 1627 1631	5-FU
N1016 	Reference T51 MeSH:D005472	5-FU
N1017 	Reference T51 MeSH:D005472	5-FU
T57	Pharmacological_substance 1489 1503	DPD inhibitors
T60	Manner_cue 20 26	severe
T61	Speculation_cue 1595 1599	risk
T52	Manner_cue 1604 1610	severe
T55	Manner_cue 744 750	severe
T62	Disorder 751 763	side effects
N27 	Reference T62 UMLS:C0879626	side effects
T14	Disorder 718 731	DPD deficient
N28 	Reference T14 UMLS:C1959620	DPD deficient
N29 	Reference T14 UMLS:C1959620	DPD deficient
